ArticleClinical trials (London, England)2022

An adaptive clinical trial design to identify the target dose of tenecteplase for treatment of acute pulmonary embolism.

Sharon D Yeatts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.